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Encapsulated ferritins belong to the 
universally distributed ferritin superfamily, 
which function as iron detoxification and 
storage systems. Encapsulated ferritins have a 
distinct annular structure and must associate 
with an encapsulin nanocage to form a 
competent iron store that is capable of holding 
significantly more iron than classical ferritins. 
The catalytic mechanism of iron oxidation in 
the ferritin family is still an open question, due 
to differences in organization of the 
ferroxidase catalytic site and neighboring 
secondary metal binding sites. We have 
previously identified a putative metal binding 
site on the inner surface of the Rhodospirillum 
rubrum encapsulated ferritin at the interface 
between the two-helix subunits and proximal 
to the ferroxidase center. Here we present a 
comprehensive structural and functional study 
to investigate the functional relevance of this 
putative iron entry site by means of enzymatic 
assays, mass-spectrometry, and X-ray 
crystallography. We show that catalysis occurs 
in the ferroxidase center and suggest a dual 
role for the secondary site, which both serves 
to attract metal ions to the ferroxidase center 
and acts as a flow-restricting valve to limit the 
activity of the ferroxidase center. Moreover, 
confinement of encapsulated ferritins within 
the encapsulin nanocage, while enhancing the 
ability of the encapsulated ferritin to undergo 
catalysis, does not influence the function of the 
secondary site. Our study demonstrates a novel 
molecular mechanism by which substrate flux 
to the ferroxidase center is controlled, 
potentially to ensure that iron oxidation is 




The ferritin superfamily consists of a number 
of structurally and functionally distinct 
members, each of which is built around a four-
helix bundle scaffold which forms an iron-
binding di-iron ferroxidase active site (the 
ferroxidase center, FOC) (1). The quaternary 
structure of these protein families shows a high 
degree of variation: from monomeric 
rubrerythrin proteins (2, 3); dimeric iron-
mineralizing encapsulin-associated firmicute 
(IMEF) proteins (4); dodecameric DNA 
Protection in Starved (DPS) cells proteins and 
DPS-like (DPSL) proteins (5–9); the 24-meric 
classical ferritins (Ftn) and bacterioferritins 
(Bfr) (10–13); and the decameric encapsulated 
ferritins (EncFtn) (14, 15). The rubrerythrin 
and DPS proteins play key roles in the 
protection of cells from oxidative stress, while 
DPS and the other members of the ferritin 
superfamily are vital iron stores (7, 16–22). 
These latter proteins oxidize and convert free 
Fe(II) to inert Fe(III) oxyhydroxide or Fe(III) 
phosphate mineral forms that provide a 
reservoir of bioavailable iron (23). The 
nanocages formed by the quaternary structure 
of DPS, DPSL, Ftn, and Bfr allow iron 
oxidation and mineralization to occur within a 
biochemically privileged environment within 
the cell, which protects the host cell from iron-
induced oxidative stress. Interestingly, the 
recently described IMEF and EncFtn proteins 
both have ferroxidase activity, but they do not 
form nanocage structures on their own, instead 
they must be localized to the lumen of 
encapsulin nanocages to form a competent 
iron-store (4, 14, 15). EncFtn and IMEF are 
directed into encapsulins by a terminal 
localization sequence that binds to the interior 
wall of encapsulin. The EncFtn proteins form 
a distinct homodecameric annular assembly, 
comprising a pentamer of dimers with D5 
symmetry (Figure 1A). Each EncFtn subunit is 
formed of two long anti-parallel helices (α1 
and α2) followed by a shorter helix (α3) 
(Figure 1B); this is in contrast to the classical 
ferritins, which have 4-helix subunits. The 
annular assembly has two classes of 2-fold 
symmetry forming two distinct dimer 
interfaces. One of the dimer assemblies 
contains the FOC across the dimer interface, 
with the two iron ions bound within the 
interface (Figure 1C, FOC dimer). The other 
dimer forms a back-to-back conformation, 
exposing the metal ion binding residues and is 
known as the non-FOC dimer (Figure 1D) 
(24).  
A model for the engagement of EncFtn 
decamers with the encapsulin nanocage has 
been proposed based on the crystallographic 
model of the Thermotoga maritima encapsulin 
complex (15, 25). In this model the C-terminal 
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encapsulation sequence of the EncFtn interacts 
with a specific binding site on the encapsulin 
monomer, which is oriented to face the lumen 
of the nanocage (Figure S1). This model places 
the central hole of the EncFtn decamer directly 
under the pores formed at the icosahedral 5-
fold axis of the encapsulin nanocage, which 
would form a pathway for iron to transit across 
the encapsulin shell towards the putative metal 
entry site. The residues lining the five-fold 
pore in the encapsulin nanocage are not well 
conserved between species; and based on 
crystallographic evidence, this pore is 
primarily made up of main-chain atoms, 
implying that this pore does not have a role as 
a selectivity filter. 
 
The catalytic route to iron mineralization in the 
different ferritin iron-stores is still a subject of 
vigorous debate (23, 26–30). Given the lack of 
absolute conservation in structure of the 
ferroxidase center, it is likely that there is no 
single conserved mechanism for their activity 
(23, 26–30). All of the ferritin family proteins 
that have been structurally characterized have 
additional iron-binding sites proximal to the 
ferroxidase center. In the case of the sites 
proximal to the ferroxidase center identified in 
DPS and ferritins, these have been suggested 
to be iron-entry, transit, and exit points from 
the ferroxidase center (31–33), or the sites of 
electron transfer from Fe(II) substrates to the 
FOC (34). The subunit boundaries in the DPS 
and ferritin nanocages form a variety of 
symmetrical pores, which have variously been 
suggested, or shown, to be entry and exit sites 
to the lumen for iron, water and phosphate 
substrates (4, 10, 35–37). The proposed iron 
entry site in DPSL is distinct to other ferritin 
family proteins, with an unusual arrangement 
of cysteine residues and a disulfide bond (8). 
Furthermore, an additional metal-binding site 
located on the inner surface of the dodecamer 
has been identified in members of the DPSL 
proteins, because of its location this site is 
reminiscent of the third iron site in E. coli 
ferritins and bacterioferritins and it is proposed 
to be involved in the iron translocation through 
the protein shell (9). Whatever their function, 
these secondary metal sites are essential to the 
correct functioning of the ferritin iron-stores 
(38–40). 
 
In our previous work we identified a number 
of conserved secondary metal-binding sites in 
EncFtn proteins (14, 15). A partially occupied 
metal ion site was present on the outer surface 
(proposed exit site) of the EncFtn decamer, and 
a highly occupied metal ion site was present on 
the inner face (proposed entry site), which is 
proximal to the ferroxidase center (Figure 2A 
and B). Both of these sites are found at dimer 
interfaces between the two-helix EncFtn 
subunits and are formed when the four-helical 
ferritin fold is reconstituted by the iron-
mediated assembly of the EncFtn ferroxidase 
center (24). A comparison of these sites to 
secondary metal binding sites in other ferritin 
family members highlights the fact that ‘C’ 
site, first identified in the E. coli ferritin (41, 
42), is topologically similar to the proposed 
iron-exit site identified in our previous work, 
whereas the entry site is unique to the EncFtn 
family (15).  In our structure of the R. rubrum 
EncFtn protein, the entry site coordinates a 
calcium ion from the crystallization solution in 
a symmetrical arrangement of glutamic acid 
residues (E31/E34) and a tryptophan residue 
(W38) contributed by each chain from the 
ferroxidase center dimer (24) (Figure 2B). The 
metal coordination distances between the side 
chain carboxylic acid oxygens and calcium ion 
are 2.1 Å Ca – Glu31-Ox, 2.7 Å Glu34 – Ox, 
which are similar to the Fe – Glu – Ox 
coordination distances seen in the FOC of 2.2-
2.6 Å.  
 
We hypothesize that this site acts as an entry 
site for iron ions approaching the ferroxidase 
center, and acts in some way to control the 
access of metal ions to the active site of the 
protein (Figure 2C). The glutamic acid 
residues in the entry site are arranged in such a 
way as to capture and coordinate an Fe(II) ion 
in an octahedral geometry before passing it to 
the FOC. The positioning of W38 adjacent to 
this site suggests that the indole ring sterically 
constrains the position of the E31 side chain to 
an optimal position for metal coordination. We 
have considered several hypotheses regarding 
the functional role of the entry site, including 
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acting as a flow restrictor valve to limit the 
flow of metal ions to the FOC (“valve” 
function); an electrostatic funnel to direct 
metal ions to the FOC (“attraction” function); 
a discriminatory filter to avoid mis-metalation 
and consequent inhibition of the active site 
(“filter” function) (Figure 2D/E/F); or for 
protein stability and assembly (“stabilizing” 
function). It is also possible that these 
functions may overlap, and the entry site may 
play a number of key roles in the stability and 
activity of the encapsulated ferritins.  
 
In order to understand the role of the entry site, 
a number of single-point amino acid variants 
of the R. rubrum EncFtn protein were 
produced to replace the residue of interest with 
non-metal binding residues. These variants 
were produced in the isolated R. rubrum 
EncFtn protein alone and in an R. rubrum 
Encapsulin:EncFtn (Enc:EncFtn) co-
expression system. We produced and purified 
recombinant E31A, E34A and W38G/A 
variants of EncFtn and the Enc:EncFtn 
complex and analyzed the solution and gas 
phase behavior of these proteins to understand 
the influence of these variants on the stability 
of the EncFtn complex. We obtained X-ray 
crystal structures of the E31A and E34A 
variants of the EncFtn protein, finding that 
their structures display altered entry site 
geometry and the abrogation of metal binding 
in this site. The functional role of the entry site 
was explored biochemically; we show that 
changes to the metal coordinating amino acids 
in this site enhance the ferroxidase activity of 
the EncFtn protein, while increasing its 
susceptibility to inhibition by competing zinc 
ions. Taken together, these results indicate that 
the entry site plays a minor role in stabilizing 
the oligomeric state of the EncFtn decamer, 
and has a dual role as a site of metal ion 
attraction and as a flow restrictor valve to limit 
metal access to the ferroxidase center and thus 




Changes to the metal ion entry site of 
Encapsulated ferritins affect their oligomeric 
state in solution 
In order to explore the functional roles of the 
residues in the entry site of the R. rubrum 
EncFtn, single point variants were produced by 
site-directed mutagenesis, removing each 
metal binding residue in turn and substituting 
each with alanine or glycine. The average 
molecular masses of the EncFtn proteins were 
confirmed by liquid chromatography-mass 
spectrometry (LC-MS, Table S1). The 
resulting variants were also generated in 
association with the encapsulin (Enc) to 
produce Enc:EncFtn complexes.  
 
Changes to the ferroxidase center affect both 
the assembly and activity of the R. rubrum 
EncFtn (EncFtn-WT) (15). To investigate 
whether changes to the entry site influence the 
quaternary structure of the EncFtn protein, 
each variant was subjected to size-exclusion 
chromatography using a HiLoad 16/60 
Superdex 200 (S200) column calibrated with 
standards of known molecular mass (Figure 
3A and B). Each of the variant EncFtn proteins 
eluted with a similar profile, with a major peak 
at 60 ml retention volume, a second peak at 75 
ml, and the final peak at 82 ml (Figure 3A, 
Figure S2A, Table S2). The E34A variant had 
significantly more protein in the 82 ml peak 
when compared to the EncFtn-WT and E31A 
variant, suggesting that this change affects the 
stability of the protein complex. Based on our 
prior work, these peaks correspond to decamer, 
tetramer, and dimer species, respectively (14, 
24).  
 
In contrast to the EncFtn variants, the 
Enc:EncFtn protein complexes all eluted as a 
single peak within the void volume of the S200 
column, indicating the formation of  protein 
complexes larger than 600,000 Da (separation 
range Mr for this column is 10,000-600,000 
Da), hence not able to enter the matrix pores 
(Figure 3B, Figure S2B, Table S2). SDS-
PAGE analysis of peak fractions confirmed the 
presence of both the EncFtn and encapsulin 
proteins (Figure S3A). We performed 
transmission electron microscopy to determine 
if these complexes assembled into encapsulin 
nanocages (Figure S2D/E and Figure S3B). All 
samples showed characteristic 25 nm 
encapsulin cages, with visible internal density 
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for the EncFtn proteins. This is consistent with 
our previous observations of the R. rubrum 
encapsulin:EncFtn complex (15). 
 
X-ray crystal structures of EncFtn variants 
show altered metal binding within the entry 
site 
Given the observation that the E31A and E34A 
EncFtn variants display some differences in 
terms of oligomeric state and stability in 
solution, we determined the X-ray crystal 
structures of C-terminal hexa-histidine tagged 
variants of these proteins (EncFtn-sH). Both 
the E31A and E34A variants crystallized in 
similar conditions to EncFtn-WT; however, 
we were unable to obtain crystals of either the 
W38G or W38A variants of the EncFtn 
protein, suggesting that removing this 
tryptophan destabilizes the quaternary 
structure of the protein sufficiently to present a 
barrier to crystallization.  
 
The structures of the R. rubrum EncFtn-sH 
E31A and E34A variants were determined by 
X-ray crystallography to 2.66 and 2.19 Å 
resolution respectively. They adopt the same 
overall quaternary fold as EncFtn-WT, with 
root-mean-square deviation (RMSD) Ca 
differences of 0.2 A2 over 91 Ca and 0.17 Å2 
over 90 Ca for the E31A and E34A variants 
respectively, and an RMSD Cα of 0.23 Å2 over 
90 Ca between the two variants. This indicates 
that these amino acid substitutions do not 
significantly alter the structure of the 
polypeptide backbone in the E31A and E34A 
variants. The position of side chains in the 
FOC and their metal coordination geometry 
are conserved for both variants, indicating that 
changes to the entry site do not fundamentally 
change the structure of the FOC.  
 
Analysis of the entry site of the E31A variant 
shows that octahedral metal ion coordination 
seen for the wild-type protein is disrupted 
(Figure 4), with a weak electron density feature 
at approximately 4 Å distance from the 
carboxyl oxygens of Glu34 (Figure S4A). It 
was not possible to unambiguously model this 
feature, but it may be interpreted as a partially 
occupied divalent cation, such as calcium, 
which is present at 140 mM in the 
crystallization solution. Loss of the 
coordinating Glu31 side chain ligand causes 
Trp38 to move when compared to the wild-
type protein; this residue is found in two 
predominant conformations in this site, where 
it moves closer to the Glu34 side chain 
(Supplementary Movie 1). The change in 
metal ion binding when compared to the wild 
type protein can be ascribed to the change in 
the coordination environment around this site. 
Similarly, the entry site of the E34A variant 
does not appear to coordinate any metal ions 
and the side chain of Glu31 is flipped away by 
120° from this site (Figure 4, Figure S4B), and 
the Trp38 indole ring is also moved away from 
this site when compared to EncFtn-WT 
(Supplementary Movie 2). Together, the local 
structural changes seen for both entry site 
variants disrupt the metal coordination in this 
site when compared to the wild-type protein.  
 
Native mass spectrometry reveals 
conformational heterogeneity in the EncFtn 
variants. 
 To interrogate the stability and oligomeric 
states of the EncFtn variants, we performed 
native MS and ion mobility MS experiments 
on samples purified by size-exclusion 
chromatography (Figure 5) (14). In our initial 
studies we found that EncFtn-W38A was not 
amenable to native mass spectrometry analysis 
due to poor solubility in native MS ammonium 
acetate buffer; consequently, native MS was 
performed on EncFtn-WT, EncFtn-E31A, 
EncFtn-E34A, and EncFtn-W38G.   
 
In native MS analysis, EncFtn-E31A behaves 
similarly to EncFtn-WT and presents solely as 
a decameric charge state distribution centered 
around the 25+ charge state (Figure 5, pink 
triangles). In contrast, under the same 
instrument conditions, EncFtn-E34A and 
EncFtn-W38G displayed both decameric and 
monomeric charge state distributions (Figure 
5, highlighted with pink triangles and blue 
circles, respectively). The presence of 
monomeric high charge states (8+ to 16+ for 
EncFtn-E34A, and 8+ to 15+ for EncFtn-
W38G) suggests a degree of gas phase 
dissociation of the decameric complex during 
native MS analysis. Even with careful control 
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of instrument conditions, this monomeric 
dissociation product could not be completely 
eliminated, suggesting that complexes of the 
EncFtn-E34A and EncFtn-W38G are less 
stable than EncFtn-WT. Thus, these initial 
observations suggest that loss of either E34 or 
W38 results in gas phase destabilization of the 
decamer assembly, although we cannot rule 
out the observed difference in stability being 
due to different iron content within the FOC in 
each of these protein preparations. We also 
note that the decameric charge state 
distributions of EncFtn-WT, EncFtn-E34A 
and EncFtn-W38G are extended and include 
several additional higher charge, low 
abundance charge states (Figure 5, highlighted 
with *) when compared to our previous EncFtn 
native MS analysis of a truncated EncFtn-WT 
protein (15). We attribute their presence to the 
ability of the solvent-exposed encapsulation 
sequence to readily protonate in solution. The 
difference in gas phase stability of the EncFtn 
variants was also evident when increasing the 
sampling cone voltage and/or activating the 
trap voltage of the mass spectrometer, which 
activates the complex and causes dissociation 
(Figure S5).  
 
To further investigate the gas phase structure 
and stability of the variants, ion mobility 
collision induced unfolding (CIU) experiments 
were performed (43, 44). Each gas phase 
decamer protein complex was activated in a 
stepwise manner by incremental changes of the 
trap voltage prior to analysis of the 
conformation of the native protein ions using 
ion mobility mass spectrometry. The resulting 
ion mobility profile (arrival time distributions) 
for an individual protein ion is then plotted as 
a function of activation voltage to produce a 
heat map to reveal discrete conformations and 
gas phase unfolding transitions (Figure S6 A-
D). It is clear from these experiments that two 
major discrete conformations of each EncFtn 
variant are observed during CIU; a 
conformation with a compact structure and a 
second conformation with a more extended, 
unfolded structure (Figure S6 A-D labelled ‘C’ 
and ‘E’ respectively, and Figure S6 E i and ii). 
At minimal activation, EncFtn-WT, EncFtn-
E34A and EncFtn-E31A all exist in a single, 
compact decameric conformation with a drift 
time of between 10 and 11 ms, suggesting the 
same overall structure. As activation is 
increased, all three variants undergo a discrete 
transition to a more extended conformation 
(characterized by a drift time of 12.5 ms). A 
second more complex transition to higher drift 
time is also observed at high activation (around 
45V) before dissociation of the complex to 
release monomeric subunits. The transition 
from the C to E states for each variant was 
quantified using CIU50 values (the collision 
voltage required to convert 50 percent of the 
compact protein form into the adjacent 
extended state) to give values of 35.2 V, 26.5 
V, and 35.1 V for EncFtn-WT, EncFtn-E31A 
and EncFtn-E34A respectively. The close 
similarity of these CIU profiles strongly 
suggests similar gas phase structures for the 
EncFtn-WT and the E31A and E34A variants 
(Figure S6) with a slight destabilizing effect 
resulting from the mutation of E31 residue. In 
contrast, EncFtn-W38G occurs in the more 
extended conformation (12.5 ms) throughout 
the CIU experiment (Figure S6 D and Figure 
S6 E iii), with the compact conformation only 
observed as a minor species at low activations. 
As there is already less than 50 percent of 
compact conformation present in the lowest 
activating conditions, no CIU50 can be 
established for the transition from compact to 
extended state for W38G. EncFtn-W38G also 
undergoes a more complex transition from the 
extended conformation but with a lower 
CIU50 of 35.2 V compared to the other 
variants of approximately 45 V. This is in 
accord with the native MS studies and suggests 
that although the W38G assembly shares 
similar overall structure to the WT and 
glutamate variants, the tryptophan substitution 
has a significant destabilizing effect on the 
decameric assembly. This increased 
structural/conformational heterogeneity in the 
tryptophan variant of EncFtn may account for 
our inability to obtain crystals in standard 
crystal screens.  
 
The EncFtn metal entry site acts to attract 
metals to the FOC and restrict its catalytic 
activity 
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The changes in metal ion coordination 
observed in the entry sites in the crystal 
structures of the E31A and E34A variants 
suggest that these residues play a direct role in 
controlling the accessibility of the ferroxidase 
center to metal ions. To test our hypotheses 
about the functional role of this site (Figure 2 
D,E,F), we investigated the ferroxidase 
activity of all of the EncFtn variants produced, 
both in isolation, and in complex with the 
encapsulin protein.   
 
The ferroxidase activity of the wild-type 
EncFtn protein was confirmed to be 
comparable to that previously determined for 
the EncFtn-strepII variant (14). Surprisingly, 
all three variants displayed higher catalytic 
activity than the wild-type protein (Figure 6). 
The EncFtn-E34A variant had a 2-fold higher 
activity, while both the W38A and E31A 
mutations oxidize Fe(II) to Fe(III) around 5-
fold faster, and their progress curves present a 
distinct shape in contrast to the wild-type 
protein (Figure 6). In order to test the 
contribution of Trp38 to the EncFtn catalytic 
activity we tested the W38A variant, allowing 
for a direct comparison with the other variants. 
We also verified that the W38G and W38A 
variants had comparable activities in complex 
with the Encapsulin protein (Figure S2C). 
 
The increase in activity observed by all of 
these variants suggest that the entry site plays 
a role in restricting the flow of substrate Fe(II) 
ions to the FOC. When the differences in 
enzymatic activity are considered in the 
context of the X-ray crystal structures, it is 
clear that the disruption of metal coordination 
in the entry site has a significant impact on the 
catalytic activity of the EncFtn protein. The 
EncFtn-E31A structure shows that, as a 
consequence of changes in metal ion 
coordination, the restriction in metal ion flow 
provided by this variant is partially removed 
when compared to EncFtn-WT. However, the 
residual glutamic acid, Glu34, may still be able 
to coordinate metal ions, albeit with lower 
affinity than the wild-type enzyme, given the 
increased distance between these residues and 
lack of additional coordination from Glu31 
(Figure 4).  
 
The crystal structure of the EncFtn-E34A 
variant shows that the mutation of Glu34 to 
Ala results in a reorganization of the entry site, 
with the side chain of Glu31 reoriented in such 
a way that it is no longer correctly positioned 
for metal coordination, essentially removing 
any electrostatic attraction and flow restriction 
for this site (Figure 4). A ferroxidase assay 
carried out with an EncFtn-E31A/E34A 
variant shows that its activity is comparable to 
EncFtn-E34A (Figure S7). These data 
corroborate our hypothesis that in EncFtn-
E34A, the flow restricting function is 
completely abolished, and no attraction is 
conveyed by the residual Glu31. As no flow 
restriction is provided at this level, we would 
expect to observe a higher activity, however 
the restructuring of this site results in a loss of 
attractive forces, and consequently only a 
modest increase in activity is observed when 
compared to EncFtn-WT. The difference in 
activity between EncFtn-E31A and EncFtn-
E34A demonstrates that the electrostatic 
attraction provided by Glu34 plays an 
important role in the attraction of metal ions to 
the FOC.  
 
As we were unable to produce crystals of the 
W38A variant, we could not determine the 
effect of removing this tryptophan residue on 
the structure of the entry site. Analysis of our 
crystal structures shows that the indole ring of 
the tryptophan may act to sterically constrain 
the Glu31 side chain in the correct position for 
metal-coordination. Consequently, it is 
possible that the removal of Trp38 results in 
the Glu31 side chain moving away from this 
site. Our ferroxidase assay data show that the 
Trp38 variants have a comparable activity 
profiles to the E31A variant; we therefore 
propose that the two variants possess similar 
entry site structures. The broader destabilizing 
effects of the loss of the tryptophan side chain 
are harder to model, but the loss of a side chain 
of the size of the tryptophan indole may lead to 
further structural rearrangements around the 
internal dimer interfaces engaged by this 
residue.  
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The same ferroxidase assay was performed 
with the Enc:EncFtn complex, with wild type 
and EncFtn variants (Figure 6B). The 
deviations from wild type behavior were 
compared to those observed in the absence of 
the encapsulin nanocompartment (Figure 6A). 
Enzymatic reaction initial rates (v0) were 
calculated for each of the variants (in the first 
200 s of the assay) and then divided by the 
initial rate of the corresponding wild-type 
protein (EncFtn-WT or Enc:EncFtn-WT) 
(Figure S8, Tables S3, S4 and S5). This 
allowed comparison of the assay data across 
the two contexts for the EncFtn enzyme 
(encapsulated vs non-encapsulated). Our data 
show that the E31A and W38A variants have a 
greater effect on activity within both systems 
(about 4-fold faster when compared to wild 
type initial rate) while the E34A variant 
displays a 2-fold increase in the initial velocity 
v0 (Figure S8, Table S5). Therefore, the EncFtn 
variants and wild type retain the same relative 
differences in their activities whether they are 
associated to the encapsulin shell, or not. This 
observation suggests that the attraction and 
flow restricting properties are exerted by the 
entry site and are not changed by the 
sequestration of the EncFtn within the 
encapsulin cage. 
 
The ferroxidase activity of EncFtn is inhibited 
by zinc 
In order to test the hypothesis that the entry site 
acts as a selectivity filter and is able to 
discriminate between metal ions approaching 
the FOC, ferroxidase assays were performed 
with the addition of zinc as a competitive 
inhibitor (45). The activity of EncFtn wild-
type and variant proteins (10 µM, monomer) 
with 50 µM Fe(II) was assayed in the presence 
of 34 µM Zn(II) (Figure 7A). The selected zinc 
concentration was previously determined to be 
the IC50 for wild-type EncFtn-strepII (14). This 
concentration was chosen to allow 
identification of the impact of inhibition across 
the set of variant proteins. In line with our 
previous observations, EncFtn-WT showed 
54% inhibition (14) (Figure 7A and B). The 
activity of the three variant proteins (E31, E34, 
W38) showed a markedly increased relative 
inhibition when compared to their activity in 
the absence of zinc (88%, 66%, and 69%, 
respectively) (Figures 7A and B). The 
increased inhibition seen in the variants can be 
explained by the changes in metal coordination 
at the entry site. With all the variants, the 
abrogation of metal coordination at this site 
permits greater access to the FOC for 
competing metal ions, as they are no longer 
effectively captured in the entry site. While 
these data show that the entry site restricts the 
general accessibility of the FOC to competing 
metal ions, they do not directly address the 
question of whether the site is acting as a 
selectivity filter.  
 
Steady state fluorescence emission reveals zinc 
ion binding at the entry site 
To determine if zinc ions interact with the 
entry site and thus compete with iron for access 
to the FOC, intrinsic tryptophan fluorescence 
was exploited to study the Trp38 
microenvironment in the presence and absence 
of zinc sulfate. In addition to Trp38, EncFtn 
possesses two additional tryptophan residues 
(W72 and W80), one phenylalanine (F89), and 
two tyrosine residues (Y39 and Y87). Tyr39 is 
located in close proximity to the FOC and 
Glu31/Glu34, while the other aromatic 
residues are > 10 Å from both metal-
coordination sites. Therefore, any observed 
change in the protein fluorescence emission 
should be due to changes in the entry site, and 
hence to metal binding at this site. This 
hypothesis was tested by monitoring steady 
state fluorescence emission of EncFtn proteins 
over time and upon addition of increasing sub-
stoichiometric concentrations of Zn(II). The 
control experiment with EncFtn-W38A 
showed an hypsochromic shift of 8 nm in the 
emission maximum (λEM ~ 322 nm compared 
to λEM ~ 330 nm of EncFtn-WT) (Figure S9A), 
suggesting a contribution to intrinsic 
fluorescence from more buried residues in the 
absence of Trp38. Although this variant still 
possesses both glutamic acid residues in the 
entry site, no specific trend was observed upon 
zinc addition (Figure 8). 
  
Only wild-type EncFtn and the E31A variant 
showed quenching of their fluorescence 
emission on addition of zinc, with an inflection 
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at ~1 molar equivalent of Zn(II) per entry site 
(Figure 8, Figure S9B,C). Variants with 
abrogated metal coordination (E34A and 
E31A/E34A) did not show any specific trend, 
or inflection upon zinc addition (Figure 8, 
Figure S9F). Moreover, tryptophan 
fluorescence is highly influenced by the 
solvent polarity of the surrounding 
environment and fluorescence emission 
spectra from both E34A and E31A/E34A 
variants exhibited a bathochromic shift of 25 
nm (λEM ~ 355 nm), implying an increasing 
polarity in Trp38 surroundings (Figure S9A). 
These observations suggest that upon metal 
coordination, the Trp38 indole ring is 
restrained towards the gateway of the channel 
leading to FOC. 
 
Thus, we propose that metal ions can indeed 
interact with the entry site when it is intact 
(wild type), or partially present (E31A). In the 
absence of the entry site, Zn(II) will likely 
reach the FOC, an event that is not detectable 
with this assay, but shown by ferroxidase 
analysis in the presence of Zn(II) where 
increased inhibition of all variants was 
observed. 
 
Zn(II) displaces Fe(II) in the FOC and 
stabilizes the FOC dimer interface 
Given the observation in the intrinsic 
tryptophan fluorescence experiments that zinc 
directly interacts with the entry site, we 
performed high-resolution native FT-ICR MS 
to further probe whether this site was acting as 
a selectivity filter to restrict the passage of 
competing ions to the FOC. The high mass 
resolution of FT-ICR MS affords isotopic 
resolution of native protein complexes and, 
when applied to the study of metalloproteins, 
allows assignment of coordinated metals with 
high confidence. To further aid this analysis, 
we also employed an isotope depletion strategy 
(46). The depletion of 13C and 15N stable 
isotopes from the EncFtn protein sample 
(referred to as ID-EncFtn)  results in a 
dramatically reduced isotope distribution in 
mass spectrometry analysis. This simplified 
signal results in increased sensitivity and, most 
importantly for native MS analysis, reduces 
the occurrence of overlapping signals from 
proteoforms of similar mass, such as complete 
separation of sodiated and potassiated protein 
ions (a common observation in native protein 
MS). Thus, this strategy simplifies data 
interpretation and allows more confident and 
precise assignment of metal bound species. 
Native FT-ICR analysis of apo-ID-EncFtn 
reveals that it exists exclusively as a monomer 
(Figure 9A), as previously seen for EncFtn 
expressed in minimal media (15). Isotopic 
resolution confirms there is no metal bound 
within the purified ID-EncFtn monomer; 
which is as predicted, due to the limited 
bioavailability of metals in the minimal media 
required for the production of isotopically 
depleted proteins (Figure S10 A). Titration 
with Fe(II) prior to MS analysis results in the 
disappearance of the monomeric species and 
the appearance of a decameric charge state 
distribution (Figure 9B, pink triangles). This 
result is consistent with the Fe(II)-dependent 
assembly of EncFtn (15). Interestingly, 
titration with Zn(II) prior to native MS reveals 
a similar result (Figure 9C, pink triangles), 
supporting our previous solution-phase 
observations that metal-mediated higher order 
assembly is not specific for iron (15). Loading 
ID-EncFtn with Fe(II) followed by the addition 
of Zn(II) results in a decameric charge 
distribution similar to that of the Zn(II)-
mediated decamer (Figure 9D). Isotopic 
resolution cannot be achieved for the 
decameric species due to heterogenous metal 
loading, but sufficient mass resolving power 
indicates metal loading occurs to the 
decameric complex in each case (Figure S10 
B).  We used collision-induced dissociation 
(CID) to perform gas phase disruption 
experiments to gain additional understanding 
of metal loading in ID-EncFtn. Iron-loaded ID-
EncFtn dissociates predominantly into a high-
charge monomer species, the so-called 
‘typical’ dissociation product of protein 
complexes (47). However, upon closer 
inspection, evidence of higher order collision 
induced subcomplexes is present - a minor 
tetramer species is observed at m/z 3552 
(charge 14+) (Figure S11 A i, blue circles and 
purple diamond respectively). This species has 
low signal-to-noise ratio (S/N); however, its 
depleted isotope distribution is similar to that 
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of four ID-EncFtn monomers with two Fe(III) 
ions bound (Figure S11 A ii). We assign this 
species as two non-FOC dimers bound 
together by a di-iron containing FOC, this 
dissociation pathway is consistent with the 
proposed assembly of EncFtn (24) (Figure S11 
A iii).   
 
In stark contrast, ID-EncFtn with coordinated 
Zn(II) ions dissociates into monomer and 
dimer species (Figure S11 B i, blue circles and 
green squares respectively). Isotopic 
resolution was achieved for the dimer species 
and reveals this species has a mass consistent 
with two ID-EncFtn monomers associated two 
Zn(II) ions (Figure S11 B ii ). The presence of 
two metal ions bound within the dimer 
suggests that this species is the FOC dimer 
with the FOC occupied by two Zn(II) ions. 
There is no peak observed consistent with an 
apo-dimer, nor a dimer with one, or three, 
Zn(II) ions bound. This ‘atypical’ dissociation 
pathway was previously observed for EncFtn 
(15) (Figure S11 B iii). The differing 
dissociation pathways of zinc-coordinated ID-
EncFtn and iron-coordinated ID-EncFtn 
suggests that zinc stabilizes the FOC interface 
and binds with a higher affinity than iron in the 
FOC catalytic center; this higher affinity is as 
predicted from the Irving-Williams series. 
This supports our observations from the 
ferroxidase assay that show zinc inhibiting the 
FOC. Analysis of ID-EncFtn first loaded with 
iron and then subsequently challenged with 
zinc reveals an identical dissociation pathway 
to that titrated solely with zinc (Figure S11 C 
i). Analysis of the isotopic distribution of the 
dimer species shows the same dimer species 
seen when titrated with zinc alone (Figure S11 
C ii). No iron containing dissociated 
subcomplexes were observed in the mass 
spectrum, suggesting that in EncFtn-WT, zinc 
can efficiently displace iron in the FOC. Thus, 
taken together, our native MS and biochemical 
analysis suggests that zinc inhibition acts at the 
catalytic ferroxidase center, and that zinc is not 
held within, or discriminated against, at the 
entry site (Figure S11 C iii).  
 
Discussion 
We have shown that substitution of residues in 
the entry site triad (Glu31, Glu34, Trp38) with 
non-metal binding residues results in the 
enhancement of enzymatic activity (Figure 
6A). Our crystal structures support the 
conclusion that this is a consequence of the 
creation of a wider and more loosely 
coordinating entry site, which allows the faster 
passage of metal ions to the FOC due to a 
reduced energy barrier at this site (Figure 4). 
Furthermore, when these key residues are 
removed, the protein is more susceptible to 
inhibition by Zn(II).  
 
Solution and gas-phase analyses of variant 
proteins showed that, in contrast to the FOC, 
removal of the metal coordinating ligands 
(E31A/E34A) did not have a large effect on 
protein oligomerization; however, removal of 
the Trp38 side chain had a significant 
destabilizing effect on the quaternary structure 
of the protein. Investigation of the EncFtn 
intrinsic fluorescence emission properties 
upon zinc binding revealed coordination in the 
entry site when this is intact or partially formed 
(WT and E31A, respectively), confirming that 
this site acts as an additional metal binding site 
prior to the FOC.  
 
High resolution MS analysis of ID-EncFtn 
metal binding reveals that ID-EncFtn decamer 
assembly can be induced by iron and zinc ions. 
Furthermore, zinc appears not to be trapped by 
the metal ion entry site but is bound within the 
FOC more tightly than iron and stabilizes the 
FOC dimer. When ID-EncFtn is loaded with 
iron and subsequently challenged with zinc, 
only zinc is observed bound in ID-EncFtn 
subcomplexes, indicating that zinc displaces 
iron from the FOC. 
 
Taken together, these results imply that the 
entry site has a lower affinity for metal ions 
than the ferroxidase center and that in accord 
with the Irving-Williams series the FOC forms 
more stable complexes with zinc than iron. 
However, bacterial cells buffer metal 
concentrations via a polydisperse buffer in the 
order of the Irving-William series (48–51), 
resulting in highly competitive Zn(II) ions 
being buffered to lower available levels than 
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Fe(II), thus presumably preventing the mis-
metalation of ferritin sites in vivo. 
 
These observations support the hypothesis that 
the entry site has a dual function, in attracting 
metal ions to the catalytic site, and as a flow 
restrictor to limit the movement of metal ions 
to the FOC and thus slow the rate of iron 
oxidation (Figure 2 D and F). Our results 
confirm that the ferroxidase center is indeed 
the active site of this enzyme, as the loss of the 
entry site enhances enzyme activity rather than 
abrogates it. Why the EncFtn protein has 
evolved a mechanism to effectively slow its 
activity is still an open question. There may be 
a trade-off between substrate turnover and the 
availability of a sink for the electrons liberated 
from the iron in the ferroxidase center. The 
catalytic mechanism and electron sink for 
ferritins is still a subject of vigorous debate. 
The EncFtn family presents a unique structural 
arrangement of the active site, which will no 
doubt present a distinct mechanism to other 
members of the ferritin family when probed 
further (52). The entry site may well provide a 
brake to ensure productive coupling of iron 
oxidation and mineralization.  
 
Encapsulation of the EncFtn protein within the 
encapsulin nanocage enhances the activity of 
all of the EncFtn variants (Figure 6), but does 
not change the way in which modifications to 
the entry site affect the catalytic activity, 
indicating that the function of the entry site is 
not changed through association with the 
encapsulin shell. These results suggest that the 
encapsulin shell acts to guide productive iron 
ion interactions with the EncFtn protein; 
indeed, our previous work showed that the 
encapsulin shell interacts with a significant 
amount of iron in the absence of the EncFtn 
protein. This warrants future investigation into 
the ability of the encapsulin shell to conduct 
metal ions to the EncFtn active site and the role 
of the encapsulin shell pores in the access of 




Expression constructs for the R. rubrum 
EncFtn protein (pACYCDuet-1-Rru_EncFtn) 
and Enc:EncFtn protein complex 
(pACYCDuet-1-Enc:EncFtn) were produced 
in the previous work (15).  
 
Site-directed mutagenesis to generate the 
desired variants of EncFtn and Enc:EncFtn 
was conducted via the QuikChange® protocol 
(Stratagene) using primers listed in Table S6. 
pACYCDuet-1-EncFtn (15) or pACYCDuet-
1-Enc:EncFtn (15) were used as template to 
produce single mutants, while pACYCDuet-1-
EncFtn-E31A was used to produce EncFtn-
E31A/E34A double mutant. 
 
Protein nomenclature used throughout the text 
is shown in Table S7. Primers used in this work 
for this purpose are listed in Table S6. 
 
Protein production and purification 
Expression plasmids for the R. rubrum EncFtn 
protein and Enc:EncFtn complex were 
transformed into competent Escherichia coli 
BL21(DE3) cells and grown in LB medium 
supplemented with appropriate antibiotics, and 
expressed as described previously (14, 15). 
Protein sequences are listed in Table S8. 
 
EncFtn and its variants, were expressed and 
purified as described in (14). A single colony 
of E. coli BL21(DE3) cells transformed with 
protein expression plasmid was grown 
overnight at 37 °C in 10 ml LB medium, 
supplemented with 35 µg/ml chloramphenicol 
or 50 µg/ml kanamycin, while shaking at 180 
rpm. 
The starting culture was then inoculated into 1 
l of LB medium, grown until OD600 = 0.5, and 
protein expression was induced with 1 mM 
IPTG, while the temperature was reduced to 30 
°C and the cells were incubated for a further 18 
h. Cells were pelleted by centrifugation at 4000 
g for 25 min at 4 °C and washed with PBS 
before an additional centrifugation step. 
 
EncFtn wild-type and variants cell pellets were 
resuspended in 10-times (v/w) of Buffer QA 
(50 mM Tris, pH 8.0) and lysed by sonication 
on ice (5 minutes of 30-second burst of 
sonication at 35 % amplitude and 30-second 
cool down). Cell lysate was clarified by 
ultracentrifugation at 16,000 g for 25 min at 4 
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°C, followed by filtration using a 0.22 µM 
syringe filter (Millipore, UK). EncFtn protein 
sample was applied to a 20 ml anion exchange 
column (Hi-Prep Q HP, GE Healthcare) pre-
equilibrated with Buffer QA. Un-bound 
protein was then washed off with 10 volumes 
of Buffer QA. Proteins were eluted with a 
linear gradient of 20 column volumes of 
Buffers QA and QB (50 mM Tris, pH 8.0, 1 M 
NaCl) to 100 % QB. Protein of interest was 
identified by SDS-PAGE and concentrated 
using a Vivaspin centrifugal concentrator 
(MWCO 10 kDa, Sartorius) following the 
manufacturer’s instructions. Concentrated 
sample was loaded onto a size exclusion 
column (HiLoad 16/60 Superdex 200, GE 
Healthcare) pre-equilibrated with Buffer GF 
(50 mM Tris, pH 8.0, 150 mM NaCl). 
Fractions were analyzed by 15 % SDS-PAGE 
to assess purity and oligomerization state and 
those containing the protein of interest were 
pooled and further concentrated as described 
before. 
 
Enc:EncFtn wild-type and variant complex 
cell pellets were resuspended in 10-times (v/w) 
of Lysis Buffer (20 mM HEPES pH 8.0, 2 mM 
MgCl2, 1 mg/ml lysozyme, 20 units/ml 
benzonase). Cells were sonicated on ice (5 
minutes at 30 seconds on/off cycles, 35 % 
amplitude), followed by incubation for 30 
minutes at 37 °C in a water bath. Cell lysate 
was clarified by centrifugation (35,000 x g, 30 
minutes, 4 °C) and the supernatant was 
collected and incubated for 10 minutes at 80 
°C in a water bath. After cooling the sample 
was centrifuged again (30 minutes, 35,000 x g, 
4 °C), and the supernatant was collected and 
filtered using a 0.22 µm syringe filter 
(Millipore, UK). Enc:EncFtn protein complex 
sample was loaded onto a 20 ml anion 
exchange column (Hi-Prep Q HP, GE 
Healthcare) pre-equilibrated with Buffer QA 
(50 mM Tris, pH 8.0). Un-bound protein was 
washed with Buffer QA. A linear gradient 
elution of 20 column volumes was performed 
by mixing Buffers QA and QB (50 mM Tris, 
pH 8.0, 1 M NaCl) to 100 % QB. Since 
Enc:EncFtn does not bind the anion exchange 
column, proteins of interest were found in 
flow-through sample, as confirmed by 15 % 
SDS-PAGE. Protein was concentrated using a 
Vivaspin centrifugal concentrator and then 
applied to a size exclusion column (HiLoad 
16/60 Superdex 200, GE Healthcare) pre-
equilibrated with Buffer GF (50 mM Tris, pH 
8.0, 150 mM NaCl). Fractions of interest were 
run on a 15% SDS-PAGE, and further 
concentrated using a Vivaspin centrifugal 
concentrator as before. After concentration, 
protein samples were analyzed by 10% 
Tricine-SDS-PAGE (53) in order to resolve 
bands around 30 kDa. Elution volumes of 
EncFtn and Enc:EncFtn complexes from the 
size exclusion column are listed in Table S2. 
 
His-tagged protein production and 
purification 
Hexahistidine tagged EncFtn-E31A and -
E34A variants (EncFtn-sH) were produced in 
E. coli BL21(DE3) as described above and 
purified following the same protocols as 
previously described (15). A 5 ml HisTrap 
column (GE Healthcare, UK) was equilibrated 
with Buffer HisA (50 mM Tris, 500 ml NaCl 
and 50 mM imidazole, pH 8.0) and loaded with 
the clarified cell lysate. Unbound proteins 
were washed with Buffer HisA. A step 
gradient of 50 % and 100 % HisB (50 mM Tris, 
500 ml NaCl and 500 mM imidazole, pH 8.0) 
was performed to elute His-tagged proteins. 
Fractions containing the protein of interest 
were identified by 15 % SDS-PAGE, pooled 
together and concentrated by Vivaspin 
centrifugal concentrator (10 kDa MWCO). 
Protein sample was applied to a size exclusion 
column (HiLoad 16/60 Superdex 200, GE 
Healthcare) pre-equilibrated with Buffer GF 
(50 mM Tris, pH 8.0, 150 mM NaCl). A 15 % 
SDS-PAGE was carried out to assess purity 
and oligomerization state and samples 
containing the protein were further 
concentrated as described before. 
 
Isotopically depleted strepII-tagged protein 
production and purification 
To produce isotopically depleted EncFtn 
proteins, competent E. coli BL21 (DE3) cells 
were transformed with the required expression 
plasmid. A single colony was used to inoculate 
10 ml of LB media supplemented with the 
appropriate antibiotic, before overnight 
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incubation at 37 ºC. This was then used to 
inoculate 500 ml of 2x YT media, incubated at 
37 ºC until an OD600 0.6-0.8 was obtained, at 
which point the cell culture was centrifuged at 
5000 x g at 4 ºC for 20 minutes (200 ml per 
expression culture required). The pellet was 
washed with M9 salts solution (33.9 g/L 
Na2HPO4, 15 g/L KH2PO4, 2.5 g/L NaCl) and 
suspended in 100 ml M9 minimal media. 
Isotopically depleted M9 minimal media was 
supplemented with 12C (99.9%)–glucose 
(Cambridge Isotope Laboratories) and 14N 
(99.99%)-ammonium sulfate. The M9 
minimal media cultures were further incubated 
at 37 ºC for 1 hour, before protein expression 
was induced and stored as previously 
described (46). 
 
Isotopically depleted strepII-tagged EncFtn 
(ID-EncFtn) was purified as reported in (He et 
al. 2019). Cells were suspended in 10x (v/w) 
Buffer W (100 mM Tris pH 8.0, 150 mM 
NaCl), sonicated and clarified by 
centrifugation. Cell lysate was loaded onto a 
Strep-Trap HP column (5 mL, GE Healthcare), 
equilibrated according to manufacturer's 
instructions, and unbound protein was washed 
out with Buffer W (5 column volumes). ID-
EncFtn was eluted by Buffer E (100 mM Tris 
pH 8.0, 150 mM NaCl, 2.5 mM desthiobiotin). 
 
Protein quantification 
Both untagged and His-tagged EncFtn proteins 
were quantified using the Pierce BCA Assay 
kit (Thermo Fisher Scientific) following the 
manufacturer’s instructions for the Test-tube 
procedure. Concentration of Enc:EncFtn 
proteins was determined using the Beer-
Lambert equation, measuring absorbance at 
280 nm with a Nanodrop Spectrophotometer 
(Thermo Scientific) and using an extinction 
coefficient calculated by ProtParam tool on the 
Expasy platform entering a sequence 
composed of 3 x Enc and 2 x Enc-Ftn 
sequences. This ratio was determined by 
examination of SDS-PAGE gels of 
Enc:EncFtn proteins and densitometry of 
bands. 
 
Transmission electron microscopy 
TEM imaging was performed as previously 
described (15) on purified Enc:EncFtn 
proteins. Proteins were diluted in Buffer GF to 
a final concentration of 0.1 mg/ml before being 
spotted on glow-discharged 300 mesh carbon-
coated copper grids. Excess liquid was 
removed by blotting with filter paper 
(Whatman, UK) before the sample was washed 
three times with distilled water prior to being 
stained with 0.2 % uranyl acetate, blotted 
again, and air-dried. Grids were imaged using 
a Hitachi HT7800 transmission electron 
microscope and images were collected with an 
EMSIS Xarosa camera.  
 
Protein crystallization and X-ray data 
collection 
EncFtn-sH variants (E31A or E34A) were 
concentrated to 10 mg/ml (based on extinction 
coefficient calculation) and subjected to 
crystallization under similar conditions to the 
wild-type protein (WT) (Table S9). 
Crystallization drops were set up in 24-well 
Linbro plates using the hanging drop vapor 
diffusion method at 292 K. Glass coverslips 
were set up with 1–2 μl protein mixed with 1 
μl well solution and sealed over 1 ml of well 
solution. Crystals appeared after one week to 
two months and were mounted using a 
LithoLoop (Molecular Dimensions 
Limited, UK), transferred briefly to a 
cryoprotection solution containing well 
solution supplemented with 1 mM FeSO4 (in 
0.1% (v/v) HCl) and 20% (v/v) PEG 200, and 
were subsequently flash cooled in liquid 
nitrogen.  
 
All crystallographic datasets were collected at 
10–100 eV above the experimentally 
determined Fe-Kα edge on the macromolecular 
crystallography beamlines at Diamond Light 
Source (Didcot, UK) at 100 K using Pilatus 
6M detectors. Diffraction data were integrated 
and scaled using XDS (54) and symmetry 
related reflections were merged with Aimless 
(55). Data collection statistics are shown in 
Table 1. The resolution cut-off used for 
structure determination and refinement was 
determined based on the CC1/2 criterion 
proposed by (56).  
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The structures of the EncFtn-sH variants were 
determined by molecular replacement using 
decameric wild-type protein (PDB ID: 5DA5) 
as the search model (15). A single solution 
comprising three decamers in the asymmetric 
unit was found by molecular replacement 
using Phaser (57). The initial model was 
rebuilt using Phenix.autobuild (58) followed 
by cycles of refinement with Phenix.refine 
(59), with manual rebuilding and model 
inspection in Coot (60). The final model was 
refined with isotropic B-factors, torsional NCS 
restraints, and with anomalous group 
refinement to correctly model the iron ions in 
the ferroxidase center. The model was 
validated using MolProbity (61). Structural 
superimpositions were calculated using Coot 
(60). Crystallographic figures were generated 
with PyMOL (Schrödinger, LLC.). Model 
refinement statistics are shown in Table 1. The 
final models and experimental data are 
deposited in the PDB.  
 
Mass spectrometry analysis 
LC-MS, native MS, ion mobility MS (IM-MS) 
and collision induced unfolding experiments 
were performed on a Synapt G2 ion-mobility 
equipped Q-ToF instrument (Waters Corp., 
Manchester, UK). For LC-MS analysis, an 
Acquity UPLC equipped with a reverse phase 
C4 Aeris Widepore 50 × 2.1 mm HPLC 
column (Phenomenex, CA, USA) was used 
with a gradient of 5–95%B (where A:water + 
0.1% formic acid, and B:acetonitrile + 0.1% 
formic acid) over  10 minutes. For LC-MS, 
samples were typically analyzed at 5 μM, and 
data analysis was performed using MassLynx 
v4.1 and MaxEnt deconvolution.  
For native MS analysis, all protein samples 
were buffer exchanged into ammonium acetate 
(100 mM; pH 8.0) using Micro Biospin 
Chromatography Columns (Bio-Rad, UK) 
prior to analysis and the resulting protein 
samples were analyzed at a typical final 
concentration of ~5 µM (oligomer 
concentration). Nanoelectrospray ionization 
was employed using a Nanomate infusion 
robot (Advion Biosciences, Ithaca, NY). 
Instrument parameters were tuned to preserve 
non-covalent protein complexes and were 
consistent for the analysis of the EncFtn 
variants. After native MS optimization, 
parameters were: nanoelectrospray voltage 
1.55 kV; sample cone 100 V; extractor cone 0 
V; trap collision voltage 4 V; source 
temperature 60 °C; and source backing 
pressure 4.5 mbar. IM-MS was performed 
using the travelling-wave mobility cell of the 
Synapt G2 with nitrogen drift gas. The typical 
conditions used for IM-MS were: wave 
velocity 300 m/s; wave height 19 V; and 
sampling cone of 75 V. For collision induced 
unfolding (CIU) experiments, samples were 
analyzed with incremental increasing trap 
voltages between 10 V to 60 V, using 2 V 
increments. Data was processed and CIU50 
values determined  using CIUSuite (43) and 
CIUSuite 2 (44). 
High resolution native mass spectrometry was 
performed on a 12T SolariX 2XR FT-ICR MS 
(Bruker Daltonics) equipped with a 
nanoelectrospray source. Due to the 
quadrupole range of the FT-ICR MS 
instrument used, a truncated and strep(II)-
tagged version of EncFtn-WT was used for 
these experiments. Protein samples were 
buffer exchanged into ammonium acetate (100 
mM; pH 8.0) prior to direct infusion. Source 
conditions and ion optics were optimized to 
transmit native proteins ions and when 
required, Continual Accumulation of Selected 
Ions (CASI) was employed to isolate charge 
states of interest. Typically, 2 Megaword data 
was collected in QPD (2w) mode to produce a 
6 second FID, which resulted in a typical mass 
resolving power of ca. 300,000. The resulting 
data was processed using Data Analysis 
(Bruker Daltonics). For metal titrations, fresh 
iron(II) chloride tetrahydrate or zinc acetate in 
0.1% (v/v) HCl was added to ID-EncFtn (1:1 
metal:protein concentration) prior to buffer 
exchange into ammonium acetate (100 mM; 
pH 8.0). 
 
Ferroxidase assay of EncFtn proteins 
Enzymatic activity of EncFtn proteins was 
tested by ferroxidase assay, as previously 
described (14). Fe(II) aliquots were prepared 
under anaerobic conditions by dissolving 
FeSO4×7H2O in 0.1% (v/v) HCl. Purified 
protein was diluted anaerobically in Buffer H 
(10 mM HEPES, pH 8.0, 150 mM NaCl), 
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previously purged with gaseous nitrogen, to a 
final concentration of 10 µM (EncFtn).  
Protein and ferrous iron samples were added to 
a quartz cuvette (Hellma) under aerobic 
conditions at a final concentration of 10 µM 
and 50 µM, respectively, corresponding to a 
FOC:Fe(II) ratio of 1:10. 
 
Absorbance at 315 nm was recorded every 
second for 1500 s by a UV-visible 
spectrophotometer (PerkinElmer Lambda 35), 
using the TimeDrive software. The same 
experiment was performed in the absence of 
the enzyme to determine the oxidation of 
ferrous salts by atmospheric oxygen. 
The same setup was adopted for recording the 
activity of EncFtn-E34A and EncFtn-
E31A/E34A in a separate assay at higher 
concentration (20 µM EncFtn and 100 µM 
Fe(II)) for comparison purposes. Data 
presented here are the mean of three technical 
replicates of time zero-subtracted progress 
curves with standard deviations calculated 
from the mean. 
 
Calculation of the EncFtn enzymatic reaction 
initial rate (v0) was made by applying the 
Linear Regression tool in GraphPad (Prism8) 
on the absorbance at 315 nm measured for the 
first 200 s, when curves are still linear and 
following an order zero kinetics (Figure S8, 
Table S3). Slopes obtained from these curves 
correspond to initial reaction rate. v0variant/ v0wild 
type factors were calculated by dividing the 
initial rates of the variant enzymes by the 
initial rate of the wild-type protein (Table S5). 
 
Ferroxidase assay of Enc:EncFtn protein 
complexes 
Ferroxidase assay of Enc:EncFtn protein 
complexes was performed in the same 
conditions as those used for EncFtn, but with 
different protein and iron salt concentration. 
Enc:EncFtn was diluted to a final 
concentration of 25 µM which corresponds to 
10 µM EncFtn based on a 3:2 Enc:EncFtn 
ratio, as previously observed by SDS-PAGE 
by our group (Figure 1A in (15). Fe(II) sample 
was diluted to 50 µM in the reaction system to 
maintain a final ratio of 1:10 FOC:Fe(II).  
Calculation of the Enc-EncFtn enzymatic 
reaction initial rate (v0) and v0variant/ v0wild type 
factors was carried out as described in the 
above section (Figure S8, Tables S4 and S5). 
 
Zinc inhibition of ferroxidase activity of 
EncFtn proteins 
Ferroxidase assay was performed as above 
with EncFtn (10 µM) and Fe(II) samples (50 
µM) in the presence of 34 µM ZnSO4×7H2O. 
The chosen concentration corresponds to the 
IC50 value previously determined for EncFtn-
StrepII, under the same experimental 
conditions by our group (14). Oxygen-free 
metal samples were added to the quartz cuvette 
under aerobic conditions, followed by the 
protein sample. Data were replicated three 
times and means and standard deviation of 
time zero-subtracted progress curves were 
calculated. A negative control was performed 
by monitoring A315 of Zn(II) and Fe(II) salts 
mixed in the absence of enzyme. 
 
Monitoring quenching of protein intrinsic 
fluorescence upon metal-binding 
Experiments were carried out aerobically in a 
quartz cuvette (Hellma), using a Cary Eclipse 
Fluorescence spectrophotometer. Protein was 
diluted in Buffer GF to a final concentration of 
20 µM, corresponding to 10 µM for the entry 
site. ZnSO4•7H2O stock was prepared in 
deionized water. The instrument excitation 
wavelength was set to 280 nm, corresponding 
to maximum absorption for tryptophan 
residues. 
 
Two distinct modes of detection were used; 
Kinetic option on the Analysis software 
package was chosen to record protein 
fluorescence emission signal at specific 
wavelengths over time. Pre-scans were carried 
out to find the optimal emission wavelength 
(ranging from 322 nm to 355 nm) for each 
protein variant. Metal aliquots (0.15 or 0.3 
molar equivalents) were added to the cuvette 
while pausing the data collection for fewer 
than five seconds. The final data represent 
average of 10 data points at equilibrium upon 
each metal addition. 
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The Scan option of the Analysis software 
package was chosen to record emission in the 
290-400 nm range, allowing detection of 
possible shifts in emission peak maximum 
upon metal addition. Spectra were recorded in 
triplicate at equilibrium. 
 
Data availability 
Data sets supporting this paper have been 
deposited in appropriate public data 
repositories. Please see figure legends and 
tables for links to these.
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Figure 1. EncFtn subcomplex architecture 
(A) Annular decamer structure of EncFtn shown in a side-on and top-down view, with a simplified 
representation of topology. The decamer structure has ten iron ions bound (orange spheres). (B) An 
EncFtn monomer with a simplified cartoon. (C) The FOC dimer in cartoon with two coordinated 
iron ions (shown as orange spheres) and a simplified FOC cartoon is shown with two iron ions as 




   
 




Figure 2. Hypotheses for the functional role of the entry site in EncFtn. 
(A)Side-on view of entry site and FOC within EncFtn. The metal-binding residues of the entry site 
(Glue31 and Glu34 of each subunit shown in purple and green respectively) are shown coordinating 
a metal ion ( graysphere) within the dimer interface. Iron ions coordinated in the ferroxidase center 
(FOC) are depicted as red spheres with FOC residues in blue. (B) Top-down view of the entry site 
showing Glu31, Glu34 and Trp38 of each subunit in purple, green and pink respectively. Glu31 and 
Glu34 are coordinating a divalent metal ion shown in gray. (C) The proposed iron pathway in 
EncFtn. The black arrows indicate movement of Fe(II) ions (orange spheres) in EncFtn during their 
oxidation process to Fe(III) (brown sphere). Fe(II) enters the entry site where the Glu31 and Glu34 
side chains from both subunits are shown in purple and green. Fe(II) then proceeds to the FOC and 
then leaves EncFtn as Fe(III). Several hypotheses for the role played by the residues contributing to 
the entry site are shown in D-F (flow restriction valve (D), selectivity filter (E), and attraction (F). 
Ferrous and ferric ions are depicted as orange and brown circles, respectively, while non-cognate 
species are in gray. The entry site glutmates are shown in orange and green stick representation, and 
the FOC residues are shown in shades of blue.  
  
   
 





Figure 3. Purification of recombinant EncFtn and Enc:EncFtn protein complexes. 
Recombinant EncFtn (A) and Enc:EncFtn (B) proteins were purified by anion exchange 
chromatography (Hi-Trap Q-sepharose FF, GE Healthcare) and then subjected to size-exclusion 
chromatography using a Superdex 200 16/60 column (GE Healthcare) previously equilibrated with 
50 mM Tris-HCl, pH 8.0, 150 mM NaCl. The elution profiles in A reveal that all EncFtn proteins 
show a main peak at around 60 ml, diagnostic of oligomerization states close to 10-mer, and smaller 
peaks at ~ 76 ml and 82 ml (indicative of smaller assembly states, Table S2). Enc:EncFtn protein 
complexes elute in a single peak around 46 ml, suggesting that EncFtn is compartmentalized within 
the Encapsulin shell. doi. 10.6084/m9.figshare.9885557 
 
  
   
 




Figure 4. Comparison of side-chain positions in X-ray crystal structures of EncFtn entry site 
variants.  
Residues in the putative metal ion entry site for the X-ray crystal structures of the E31A (A, green) 
and E34A (B, blue) EncFtn variants are shown with the EncFtn-sH wild-type (grey) for 
comparison. Residues in the metal ion entry site are shown as stick representations with a sphere 
indicating the position of the calcium ion found coordinated in the wild-type protein. Residues in 
the entry site are labelled, with residues from the second monomer indicated with prime symbols. In 
the E31A variant the Trp38 side chain is moved towards the putative metal ion coordinating 
residues, while the Glu34 side chain is in a similar conformation when compared to the wild type.  
The Trp38 side chain in E34A adopts a similar conformation to that seen in the E31A variant; while 
in the absence of the Glu34 side chain, the Glu31A side chain rotates by 120° away from the 
putative metal binding site.  
  
   
 





Figure 5. Native MS Analysis of EncFtn variants. 
Native nESI spectra of EncFtn variants displaying decameric (pink triangles) and monomeric (blue 
circles) charge state distributions. The elongated decameric charge state distributions of WT and 
E34A are highlighted by an asterisk. 
 
   
 





Figure 6. Ferroxidase activity of EncFtn and Enc:EncFtn complexes.  
(A) EncFtn wild-type (green line), EncFtn-E34A (pink line), EncFtn-E31A (blue line), and EncFtn-
W38A (orange line), (10 μM, monomer) were incubated with 50 μM FeSO4.7H2O (10 times molar 
equivalent Fe(II) per FOC) and progress curves of the oxidation of Fe(II) to Fe(III) was monitored 
at 315 nm at room temperature. The background oxidation of iron at 50 μM in enzyme-free control 
is shown for reference (dotted grey line). Solid lines represent the average (n = 3) of technical 
replicates, shaded areas represent standard deviation from the mean. Protein and iron samples were 
prepared anaerobically in Buffer H (10 mM HEPES pH 8.0, 150 mM NaCl), and 0.1 % (v/v) HCl, 
respectively. (B) Enc:EncFtn-WT (dark green line), Enc:EncFtn-E34A (dark pink line), 
Enc:EncFtn-E31A (dark blue line), and Enc:EncFtn-W38A (orange line) (25 μM Enc:EncFtn, 
corresponding to 10 μM EncFtn monomer) were incubated with 50 μM FeSO4.7H2O and progress 
curves of the oxidation of Fe(II) to Fe(III) was monitored at 315 nm at room temperature. The 
background oxidation of iron at 50 μM in enzyme-free control is shown for reference (dotted grey 
line). Solid lines represent the average (n = 3) of technical replicates, shaded areas represent 
standard deviation from the mean. Protein and iron samples were prepared anaerobically in Buffer 
H (10 mM HEPES pH 8.0, 150 mM NaCl), and 0.1 % (v/v) HCl, respectively. 
Comparison of data collected for W38A and W38G variants are shown in Figure S2, including 
elution profiles from gel-filtration purification steps (A/B), ferroxidase activities of Enc:EncFtn-





   
 





Figure 7. Ferroxidase activity of EncFtn wild-type and variants is inhibited by zinc. 
(A) Comparison between data shown in Figure 6A, collected in the absence of competing metals, 
are here plotted with curves from ferroxidase assays of EncFtn wild-type and variants carried out 
using [protein] = 10 µM and [Fe(II)] = 50 µM in the presence of [Zn(II)] = 34 µM. The zinc 
concentration corresponds to a response inhibited by 50% for EncFtn-Strep under the same 
experimental conditions (14). EncFtn wild-type is represented by a dark green line, EncFtn-E34A 
by a purple line, EncFtn-E31A by a pale blue line, and EncFtn-W38A by a red line. As a control, a 
mix of Fe(II) and Zn(II) salts (grey dotted line) were assayed in the absence of the enzyme. (B) 
End-point data presented in Figure 7A were plotted as columns to compare inhibition by zinc. 
Percentage of inhibition is shown above corresponding columns. Color-coding is consistent with 
Figure 7A. doi.10.6084/m9.figshare.9885575 
  
   
 





Figure 8. Intrinsic fluorescence of EncFtn wild-type and variants titrated with Zn(II). 
Fluorescence emission of EncFtn proteins (20 µM, corresponding to [entry-site] = 10 µM) at 
various wavelength (330 nm for EncFtn-WT and -E31A, 355 nm for EncFtn-E34A and 
E31A/E34A, and 322 nm for EncFtn-W38A) with excitation at 280 nm, and following titration with 
ZnSO4 .7H2O. (A/B) Fluorescence is quenched upon zinc addition, with inflection around 1 molar 
equivalents, suggesting perturbation of environment around Trp38. (C/D) In the absence of entry 
site residues available for metal coordination no quenching was observed. (E) EncFtn-W38A was 
tested as control. Symbols represent average and standard deviation of experimental replicates, 
collected at equilibrium either by Scan (n >3) or Kinetic (n = 10) options on the Cary Eclipse 
software package. Data were normalized to allow comparison. Dotted grey lines were added at 1 
molar equivalent of Zn(II) when inflection was observed. doi.10.6084/m9.figshare.11920512   
   
 





Figure 9. Native FT-ICR mass spectrum of ID-EncFtn  
Native nESI mass spectra of: apo-ID-EncFtn (A); ID-EncFtn titrated with Fe(II) (B); ID-EncFtn 
titrated with Zn(II) (C); and ID-EncFtn titrated with Fe(II) followed by Zn(II) (D). Oligomerization 
states are stressed with colored shapes, monomer in blue circles and decamer in pink triangles.  
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Table 1.  Data collection and refinement statistics. 
 E31A* E34A* 
Data collection   
Wavelength 1.74 1.74 
Resolution range 49.40 - 2.66  
(2.75 - 2.66) 
48.73 - 2.19  
(2.27 - 2.19) 
Space group P 1 21 1 P 1 21 1 










139.34   
b (°) 95.33 95.20 
Total reflections 310,119 (30,187) 906,663 (86,277) 
Unique reflections 170,103 (16,471) 31,4834 (30,221) 
Multiplicity 1.8 (1.8) 2.9 (2.9) 
Completeness (%) 93.30 (90.35) 96.37 (92.66) 
Mean I/sigma(I) 5.45 (1.40) 8.04 (1.43) 
Wilson B-factor (Å2) 39.14 33.05 
Rmerge 0.136 (0.657) 0.094 (0.688) 
Rmeas 0.184 (0.878) 0.116 (0.842) 
Rpim 0.123 (0.578) 0.065 (0.478) 
CC1/2 0.978 (0.517) 0.995 (0.579) 
CC* 0.994 (0.826) 0.999 (0.857) 
Refinement   
Reflections used in 
refinement 
170,031 (16,463) 314,739 (30,212) 
Reflections used for 
Rfree 
8,346 (794) 15,590 (1548) 
Rwork 0.195 (0.297) 0.184 (0.282) 
Rfree 0.236 (0.327) 0.212 (0.315) 
CCwork 0.946 (0.748) 0.959 (0.768) 
CCfree 0.914 (0.684) 0.952 (0.689) 




  macromolecules 21,988 22,072 
  ligands 65 48 
  solvent 329 640 
Protein residues 2680 2696 
RMS(bonds) (Å) 0.007 0.005 
RMS(angles) (°) 1.03 0.87 
Ramachandran   
favored (%) 99.69 99.77 
allowed (%) 0.31 0.23 
outliers (%) 0.00 0.00 
Rotamer outliers (%) 0.26 1.07 
Clashscore 4.79 3.01 
Average B-factor (Å2) 41.64 40.53 
  macromolecules 41.66 40.52 
  ligands 55.57 46.17 
  solvent 37.08 40.62 
PDB ID 6SUW 6SV1 
Statistics for the highest-resolution shell are shown in parentheses. *Friedel pairs are treated as 
separate reflections for data analysis and refinement.    
 
